pI: 8.2314 |
Length (AA): 292 |
MW (Da): 31486 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
11 | 274 | 1jks (A) | 5 | 226 | 15.00 | 0 | 0.93 | 0.82 | 0.87 |
47 | 288 | 4ww7 (A) | 36 | 257 | 35.00 | 0 | 1 | 0.952367 | 0.4 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | amastigotes. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127673)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G26110 | protein kinase family protein |
Babesia bovis | BBOV_III004260 | conserved hypothetical protein |
Brugia malayi | Bm1_51105 | Nori-2 protein |
Candida albicans | CaO19.4252 | similar to apple calcium/calmodulin-binding protein kinase |
Candida albicans | CaO19.11727 | similar to apple calcium/calmodulin-binding protein kinase |
Caenorhabditis elegans | CELE_F52C12.6 | Protein F52C12.6 |
Cryptosporidium parvum | cgd8_4700 | hypothetical protein |
Dictyostelium discoideum | DDB_G0279977 | BUD32 family protein kinase |
Drosophila melanogaster | Dmel_CG10673 | p53-related protein kinase ortholog |
Echinococcus granulosus | EgrG_001096800 | testis expressed sequence 9 protein |
Echinococcus granulosus | EgrG_001096900 | tp53 regulating kinase |
Entamoeba histolytica | EHI_155360 | protein kinase, putative |
Echinococcus multilocularis | EmuJ_001096900 | tp53 regulating kinase |
Echinococcus multilocularis | EmuJ_001096800 | testis expressed sequence 9 protein |
Giardia lamblia | GL50803_16796 | TP53 regulating kinase |
Homo sapiens | ENSG00000172315 | TP53 regulating kinase |
Leishmania braziliensis | LbrM.25.0750 | protein kinase, putative |
Leishmania donovani | LdBPK_250900.1 | protein kinase, putative |
Leishmania infantum | LinJ.25.0900 | protein kinase, putative |
Leishmania major | LmjF.25.0870 | protein kinase, putative |
Leishmania mexicana | LmxM.25.0870 | protein kinase, putative |
Loa Loa (eye worm) | LOAG_09194 | BUD32 protein kinase |
Mus musculus | ENSMUSG00000039725 | RIKEN cDNA 2810408M09 gene |
Mus musculus | ENSMUSG00000042854 | transformation related protein 53 regulating kinase |
Neospora caninum | NCLIV_067110 | hypothetical protein |
Oryza sativa | 4348657 | Os10g0422300 |
Plasmodium berghei | PBANKA_0805600 | EKC/KEOPS complex subunit BUD32, putative |
Plasmodium falciparum | PF3D7_0708300 | EKC/KEOPS complex subunit BUD32 |
Plasmodium knowlesi | PKNH_0106900 | EKC/KEOPS complex subunit BUD32, putative |
Plasmodium vivax | PVX_087945 | EKC/KEOPS complex subunit BUD32, putative |
Plasmodium yoelii | PY00132 | Unknown protein |
Saccharomyces cerevisiae | YGR262C | Bud32p |
Schistosoma japonicum | Sjp_0027460 | ko:K08851 TP53 regulating kinase, putative |
Schistosoma mansoni | Smp_139630 | protein kinase |
Schmidtea mediterranea | mk4.005629.05 | |
Trypanosoma brucei gambiense | Tbg972.11.890 | protein kinase, putative |
Trypanosoma brucei | Tb927.11.850 | Atypical serine/threonine protein kinase BUD32, putative |
Trypanosoma congolense | TcIL3000_0_07170 | protein kinase, putative |
Trypanosoma cruzi | TcCLB.506925.260 | Atypical serine/threonine protein kinase BUD32, putative |
Toxoplasma gondii | TGME49_278900 | protein kinase, putative |
Theileria parva | TP02_0241 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_443660 | TKL family protein kinase |
Trichomonas vaginalis | TVAG_344730 | TKL family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.03.0290 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.03.0290 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.03.0290 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.03.0290 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0805600 | Plasmodium berghei | Essential | plasmo |
TGME49_278900 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.